You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brinzolamide

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma, Open-Angle, Ocular Hypertension Trial in Winston-Salem (Brinzolamide/brimonidine ophthalmic suspension, Simbrinza

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Brinzolamide/brimonidine ophthalmic suspension
  • Simbrinza 0.2%/1% Ophthalmic Suspension
  • Winston-Salem, North Carolina
    James D. Branch Ophthalmology
Aug 18, 2022

Glaucoma, Open Angle or Ocular Hypertension Trial in Louisville (brinzolamide 1% ophthalmic suspension, Azopt 1%)

Completed
Has Results
  • Glaucoma
  • Open Angle or Ocular Hypertension
  • brinzolamide 1% ophthalmic suspension
  • Azopt 1%
  • Louisville, Kentucky
    US01
Jun 8, 2021

Glaucoma Trial (Brimonidine/timolol fixed combination drops added to travoprost, Brinzolamide/timolol fixed combination drops

Completed
  • Glaucoma
  • Brimonidine/timolol fixed combination drops added to travoprost
  • Brinzolamide/timolol fixed combination drops added to travoprost
  • (no location specified)
Dec 16, 2020

Glaucoma Trial in Miami (Latanoprost, Bimatoprost, Travoprost)

Active, not recruiting
  • Glaucoma
  • Miami, Florida
    Bascom Palmer Eye Institute - University of Miami
Oct 7, 2021

Primary Open Angle Glaucoma, Ocular Hypertension Trial in India, Russian Federation (Brinzolamide ophthalmic suspension, Azopt®)

Recruiting
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Brinzolamide ophthalmic suspension
  • Azopt®
  • Srikakulam, Andhra Pradesh, India
  • +38 more
Dec 23, 2022

Eye Diseases, Injection Complication, Intraocular Pressure Trial in Athens (Brinzolamide-brimonidine Fixed Combination)

Completed
  • Eye Diseases
  • +2 more
  • Brinzolamide-brimonidine Fixed Combination
  • Athens, Ambelokipi, Greece
    "Elpis" General Hospital
Aug 20, 2020

Glaucoma, Open-Angle, Ocular Hypertension Trial in Winston-Salem (Brinzolamide 1% ophthalmic suspension, Azopt 1% Ophthalmic

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Brinzolamide 1% ophthalmic suspension
  • Azopt 1% Ophthalmic Suspension
  • Winston-Salem, North Carolina
    James D. Branch Ophthalmology
Aug 31, 2020

Glaucoma Trial in United States (Test-Brinzolamide 1% Ophthalmic suspension, Reference-Brinzolamide 1% Ophthalmic suspension)

Completed
Has Results
  • Glaucoma
  • Test-Brinzolamide 1% Ophthalmic suspension
  • Reference-Brinzolamide 1% Ophthalmic suspension
  • Newport Beach, California
  • +9 more
Feb 28, 2020

Posterior Capsule Opacification, Ocular Hypertension Trial in Patra (Brinzolamide/Brimonidine FC, Brimonidine 0.2%, Artificial

Completed
Has Results
  • Posterior Capsule Opacification
  • Ocular Hypertension
  • Brinzolamide/Brimonidine FC
  • +2 more
  • Patra, Achaia, Greece
    University Hospital of Patras
Jun 23, 2019

High Myopia, Glaucoma, Suspect Trial in Guangzhou (Assigned Interventions: IOP-lowering eye drops)

Not yet recruiting
  • High Myopia
  • Glaucoma, Suspect
  • Assigned Interventions: IOP-lowering eye drops
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Apr 29, 2023

Open-angle Glaucoma, Ocular Hypertension Trial in Fort Worth (Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension,

Terminated
Has Results
  • Open-angle Glaucoma
  • Ocular Hypertension
  • Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
  • +2 more
  • Fort Worth, Texas
    Contact Alcon for Locations (Europe, Asia, and Latin America)
May 16, 2019

Glaucoma Trial in La Jolla (SENSIMED Triggerfish)

Completed
Has Results
  • Glaucoma
  • SENSIMED Triggerfish
  • La Jolla, California
    Hamilton Glaucoma Center, UCSD
Aug 19, 2019

Glaucoma, Suspect, High Myopia Trial in Guangzhou (IOP lowering eye drops)

Recruiting
  • Glaucoma, Suspect
  • High Myopia
  • IOP lowering eye drops
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
May 4, 2022

Glaucoma Trial in Seoul (brinzolamide 1%/brimonidine 0.2% fixed combination, Placebo, travoprost 0.004% ophthalmic solution)

Completed
Has Results
  • Glaucoma
  • brinzolamide 1%/brimonidine 0.2% fixed combination
  • +2 more
  • Seoul, Korea, Republic of
    Novartis Investigative Site
Oct 19, 2018

Glaucoma, Open-Angle Trial (Brimonidine Tartrate, Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol

Completed
  • Glaucoma, Open-Angle
  • Brimonidine Tartrate
  • +5 more
  • (no location specified)
May 24, 2019

Open-Angle Glaucoma, Ocular Hypertension Trial in Fort Worth (Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension,

Completed
Has Results
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension
  • +2 more
  • Fort Worth, Texas
    Contact Alcon Call Center for Trial Locations
Nov 13, 2018

Open-Angle Glaucoma, Ocular Hypertension Trial (Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL fixed combination eye drops,

Completed
Has Results
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL fixed combination eye drops, suspension
  • +3 more
  • (no location specified)
May 31, 2018

Central Serous Chorioretinopathy Trial in Buenos Aires, Tel Aviv (Brinzolamide Ophthalmic)

Unknown status
  • Central Serous Chorioretinopathy
  • Brinzolamide Ophthalmic
  • Buenos Aires, Argentina
  • +1 more
May 29, 2018

Glaucoma Trial (Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension, Vehicle)

Completed
Has Results
  • Glaucoma
  • Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension
  • Vehicle
  • (no location specified)
May 31, 2018

Cataract, Intraocular Pressure Trial in Patra (Brinzolamide-Brimonidine fixed combination)

Completed
  • Cataract
  • Intraocular Pressure
  • Brinzolamide-Brimonidine fixed combination
  • Patra, Achaia, Greece
    University Hospital of Patras
Apr 9, 2018

Coronary Artery Disease, Glaucoma Trial (Genetic risk assessment)

Not yet recruiting
  • Coronary Artery Disease
  • Glaucoma
  • Genetic risk assessment
  • (no location specified)
Dec 13, 2021

Retinal Dystrophies Trial (Intravitreal ranibizumab (IVR) injection, Carbonic Anhydrase Inhibitor (CAI) therapy)

Completed
  • Retinal Dystrophies
  • Intravitreal ranibizumab (IVR) injection
  • Carbonic Anhydrase Inhibitor (CAI) therapy
  • (no location specified)
Sep 20, 2019

Posner Schlossman Syndrome Trial in Beijing (FK-506 (Drug), Prednisolone Acetate 1% Oph Susp)

Recruiting
  • Posner Schlossman Syndrome
  • FK-506 (Drug)
  • Prednisolone Acetate 1% Oph Susp
  • Beijing, Beijing, China
    Peking University Third Hosipital
Aug 13, 2021

Clinical Evaluation of Patients With X-linked Retinoschisis

Completed
  • X-linked Retinoschisis
  • XLRS
  • Dorzolamide 2% TID or brinzolamide 1% TID
  • Ann Arbor, Michigan
  • +2 more
Nov 15, 2017

Primary Open-angle Glaucoma, Ocular Hypertension, Pigment Dispersion Glaucoma Trial in Mainz (Brinzolamide 1% added to

Completed
  • Primary Open-angle Glaucoma
  • +2 more
  • Brinzolamide 1% added to Travoprost 0.004%
  • Mainz, Germany
    Mainz Site
Nov 18, 2016